Stay updated with breaking news from Bpal Implementation Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BPaL shortens treatment times significantly and shows few adverse effects in patients with drug-resistant tuberculosis , according to data published in Clinical Infectious Diseases.
Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.
About 25% of 750 survey respondents met the criteria for alcohol misuse, with 5% classified as binge drinkers.
First Nations people, who are at high risk for poor COVID-19 outcomes, had robust immune responses to the Pfizer/BioNTech vaccine.